Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Transplantation. 2020 Mar;104(3):542–550. doi: 10.1097/TP.0000000000002908

Table 2.

Cause of death of SLK Recipients.

HCV negative recipients (N = 921) HCV positive recipients (N = 865)
No DGF DGF No DGF DGF
N = 660 N = 261 N = 670 N = 195
 Unknown 185 (28.0%) 71 (27.2%) 194 (29.0%) 33 (16.9%)
 Infection 127 (19.2%) 68 (26.1%) 131 (19.6%) 54 (27.7%)
 Cardiovascular 102 (15.5%) 43 (16.5%) 74 (11.0%) 29 (14.9%)
 Malignancy 73 (11.1%) 10 (3.8%) 73 (10.9%) 13 (6.7%)
 Respiratory failure 36 (5.5%) 19 (7.3%) 18 (2.7%) 7 (3.6%)
 Liver graft failure 31 (4.7%) 11 (4.2%) 61 (9.1%) 19 (9.7%)
 Kidney graft failure 18 (2.7%) 2 (0.8%) 26 (3.9%) 4 (2.1%)
 Hemorrhage 13 (2.0%) 7 (2.7%) 16 (2.4%) 3 (1.5%)
 Trauma 4 (0.6%) 2 (0.8%) 6 (0.9%) 0 (0.0%)
 Other 71 (10.8%) 28 (10.7%) 71 (10.6%) 33 (16.9%)